Department of Neurology, Mayo Clinic, Phoenix, AZ, USA.
Department of Neurology, Georgetown University, Washington, DC, USA.
Headache. 2019 Jul;59 Suppl 2:33-49. doi: 10.1111/head.13586.
Headache disorders are among the most common and disabling medical conditions worldwide. Pharmacologic acute and preventive treatments are often insufficient and poorly tolerated, and the majority of patients are unable to adhere to their migraine treatments due to these issues. With improvements in our understanding of migraine and cluster headache pathophysiology, neuromodulation devices have been developed as safe and effective acute and preventive treatment options. In this review, we focus on neuromodulation devices that have been studied for migraine and cluster headache, with special attention to those that have gained food and drug administration (FDA) clearance. We will also explore how these devices can be used in patients who might have limited pharmacologic options, including the elderly, children, and pregnant women.
头痛障碍是全球最常见和致残的医学病症之一。药物急性和预防性治疗往往不足且耐受性差,由于这些问题,大多数患者无法坚持他们的偏头痛治疗。随着我们对偏头痛和丛集性头痛病理生理学的理解的提高,神经调节设备已被开发为安全有效的急性和预防性治疗选择。在这篇综述中,我们专注于已被研究用于偏头痛和丛集性头痛的神经调节设备,特别关注那些已获得食品和药物管理局 (FDA) 批准的设备。我们还将探讨这些设备如何用于可能药物选择有限的患者,包括老年人、儿童和孕妇。